4161.TWO Bioptik Technology

Healthcare Health Care Equipment & Supplies Taiwan OTC Exchange
20.80 TWD
Close of Nov 6, 2026
19.80 28.00
Market cap
TWD 1.24B
P/E
11.2x
P/B
1.23x
ROE
11.4%
Dividend yield
1.28%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 4161.TWO undervalued?

Graham number
Price20.80
Graham value26.49
Discount21.5%

4161.TWO trades 21.5% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Bioptik Technology fundamental analysis

No fundamental analysis for Bioptik Technology yet.

Bioptik Technology stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Bioptik Technology

Bioptik Technology Incorporation engages in the manufacturing, wholesale, and retail of biotechnology and medical equipment in Taiwan and internationally. The company offers blood glucose, cholesterol, uric acid, hemoglobin and acid multi-function monitoring systems under the EasyMate, EasySure, and EasyTouch brand name, as well as PeTouch, a glucose monitoring system for dogs and cats. It also provides dietary supplements, such as capsules, gel capsules, tablets, solutions,…

Full company profile